Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Daiken Medical Co., Ltd. (7775:JPX), powered by AI.
Daiken Medical Co., Ltd. is currently trading at ¥420. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Daiken Medical Co., Ltd. on Alpha Lenz.
Daiken Medical Co., Ltd.'s P/E ratio is 11.0.
“Daiken Medical Co., Ltd. trades at a P/E of 11.0 (undervalued) with strong ROE of 15.1%.”
Ask for details →Daiken Medical Co., Ltd. is a pioneering manufacturer and supplier in the field of medical devices. The company's primary function centers around creating innovative medical solutions that enhance healthcare outcomes. With a broad portfolio, Daiken Medical is particularly noted for producing enteral nutrition products and medical infusion devices, crucial for patient care in hospitals and clinics. These products serve essential roles in supporting the nutrition and medication administration needs in medical settings, affecting various sectors such as hospitals, clinics, and home care. As a significant player in the healthcare industry, Daiken Medical Co., Ltd. contributes to advancements in patient care by offering reliable, safe, and high-quality medical devices. The company has a strong presence in the global market, driven by its commitment to innovation and meeting stringent regulatory standards. By focusing on improving the quality of life for patients, Daiken Medical plays a vital role in the overall healthcare ecosystem, supporting medical professionals in providing effective and efficient patient care.
“Daiken Medical Co., Ltd. trades at a P/E of 11.0 (undervalued) with strong ROE of 15.1%.”
Ask for details →Daiken Medical Co., Ltd. (ticker: 7775) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 180 employees. Market cap is $12.1B.
The current price is 420 with a P/E ratio of 10.99x and P/B of 1.61x.
ROE is 15.10% and operating margin is 15.19%. Annual revenue is $10.0B.